Ultralife (ULBI) Beats Q3 Views; Reaffirms FY10 Outlook
Tweet Send to a FriendGet Alerts ULBI Hot Sheet
Price: $4.00 +3.09%
EPS Growth %: +125.0%
Financial Fact:
Loss from discontinued operations, net of tax: 264K
Today's EPS Names:
TARO, SENEA, UQM, More
EPS Growth %: +125.0%
Financial Fact:
Loss from discontinued operations, net of tax: 264K
Today's EPS Names:
TARO, SENEA, UQM, More
Trade ULBI Now!
Ultralife (Nasdaq: ULBI) reports Q3 EPS of $0.26, 14 cents better than the analyst estimate of $0.12. Revenue for the quarter was $53.3 million, which compares to the estimate of $49.17 million.
Reaffirms FY10 outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Reaffirms FY10 outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Ross Stores, Inc. (ROST) Reports In-Line Q1 EPS, Raises Guidance
- Infoblox (BLOX) Tops Q3 EPS by 5c; Issues Outlook
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
